Cadmium in Functional Mushroom Supplements: What ICP-MS Testing Reveals About Your Raw Material Risk

The functional mushroom category is one of the fastest-growing segments in the supplement industry — lion’s mane, reishi, chaga, and cordyceps are everywhere right now, from specialty retailers in Lincoln Park to private-label brands shipping out of Naperville. And most of the raw material flowing into those products arrives with a supplier CoA that says something like “heavy metals: <10 ppm, compliant.”

That pass/fail language is doing a lot of heavy lifting. In many cases, it’s also hiding a real problem.

Mushrooms are cadmium hyperaccumulators. That’s not an alarmist framing — it’s a well-documented property of fungal biology. Unlike most botanical powders, where heavy metal uptake is largely a function of soil contamination and agricultural practice, mushrooms actively draw cadmium from their substrate through specialized membrane transport mechanisms. The resulting concentrations in finished powder can be orders of magnitude higher than what you’d see in, say, a standardized turmeric or ashwagandha extract from the same growing region.

What that means for any Midwest brand building a mushroom SKU: the risk profile for your incoming material is fundamentally different from the rest of your botanical portfolio. And the analytical testing laboratory you use needs to understand that difference before they report a number you can rely on.

Why Mushrooms Bioaccumulate Cadmium at Higher Rates Than Other Botanicals

Cadmium (Cd) occurs naturally in soil as a trace element, but it’s also introduced through phosphate fertilizers, industrial deposition, and — in parts of China and Eastern Europe where the majority of commercial mushroom ingredients originate — decades of accumulated agricultural and manufacturing activity. Fungal mycelia are remarkably efficient at pulling cadmium into their tissue. Studies published in journals including Food and Chemical Toxicology and Environmental Pollution have documented cadmium concentrations in commercially available mushroom powders ranging from below 0.5 ppm to above 4.0 ppm dry weight, depending on species, substrate, and growing region.

To put that in context: USP <232> — the chapter governing elemental impurities in dietary supplements and pharmaceutical products — sets a Permitted Daily Exposure (PDE) for cadmium of 4.1 µg/day for the oral route. That’s the maximum daily intake considered toxicologically acceptable, based on decades of safety data.

Do the math on a standard mushroom supplement serving. A product dosed at 1,000 mg twice daily delivers 2 grams of mushroom powder per day. If that powder contains 3.0 ppm (3.0 µg/g) of cadmium — a level that’s neither unusual nor especially alarming for commercially sourced material — that’s 6.0 µg of cadmium per day. You’ve exceeded the USP <232> PDE by nearly 50%, before accounting for cadmium from anything else in the consumer’s diet.

Chaga (Inonotus obliquus) deserves particular attention. Wild-harvested chaga, typically collected from birch trees across northern Russia and parts of Eastern Europe, has shown some of the highest cadmium readings of any commercial mushroom ingredient. Some studies have documented concentrations above 4.0 µg/g dry weight in certain wild-harvest lots. For a brand selling a 500 mg chaga capsule taken twice daily, this can put cadmium intake at or above the PDE — and the supplier’s generic “pass” on a total metals screen may have done nothing meaningful to flag it.

There’s also a less-discussed nuance around mycelium-on-grain products. A significant portion of the lion’s mane and turkey tail in the US market is myceliated grain — fungal mycelium grown on rice or oat substrate, then dried and powdered, grain and all. These products often carry lower mushroom-specific bioactive content (much of the powder is grain, not fungus), but the cadmium picture is still real and the grain substrate adds analytical matrix complexity. Knowing what you’re actually buying — fruiting body extract versus mycelium-on-grain — is a prerequisite for interpreting your elemental data correctly.

What USP <232> and <233> Actually Require from Your Lab

There’s a persistent misconception in the supplement industry that “passing heavy metals” means a product is clean for elemental impurities. It usually means total metals content fell below some internally defined threshold — often by ICP-OES or an older colorimetric method — and that threshold may or may not reflect the actual USP <232> PDEs for the elements of concern.

USP <232> classifies elemental impurities across three tiers: Class 1 (arsenic, cadmium, lead, mercury — the most toxicologically significant, with the lowest PDEs), Class 2A (oral-route specific elements including nickel, lithium, and thallium), and Class 2B and Class 3 (conditional and lower-risk elements). USP <233> defines the analytical procedure: ICP-MS or ICP-OES, with explicit method validation requirements, instrument calibration criteria, and minimum recovery targets for spiked samples at concentrations near the PDE.

A compliant elemental impurities program requires:

• Method validation to USP <233> performance criteria — accuracy between 70% and 150% recovery, adequate precision, and demonstrated linearity across the relevant concentration range
• Quantitative individual element reporting — not a summed “total heavy metals” figure, but a discrete result for each of the 24 elements in scope
• Detection limits low enough to matter — your analytical testing laboratory needs to detect cadmium at concentrations well below your product-specific control threshold, which is calculated from your serving size and the 4.1 µg/day PDE
• An ISO 17025-accredited laboratory able to demonstrate analytical competence through documented method validation and participation in proficiency testing programs

That last point matters more than it might seem. Any analytical testing laboratory can acquire an ICP-MS instrument. Far fewer have the validated methods, the accredited quality system, and the botanical matrix experience to produce results that hold up in an FDA audit or a third-party review.

What Third-Party ICP-MS Screening Is Actually Finding

Samples we receive from Midwest supplement brands through our Chicago receiving hub tell a fairly consistent story, and it isn’t uniformly alarming — but it isn’t clean either.

Lion’s mane from certified organic Chinese farms typically tests below 1.0 ppm cadmium, which is manageable at standard serving sizes. Cultivated Cordyceps militaris on grain substrate tends to run cleaner than wild-harvested Cordyceps sinensis, where environmental variability is harder to control. Reishi extract from established, traceable suppliers generally performs well.

But we’ve also screened reishi powder and chaga material — from suppliers whose CoAs read “heavy metals: pass” — where cadmium came in between 2.5 and 4.5 ppm. At those levels, a 2g daily serving pushes cadmium intake to 5.0–9.0 µg, exceeding the USP <232> PDE by up to 120%. If that material had gone straight to manufacturing without third-party ICP-MS verification, it would have gone into finished capsules, and those capsules would have gone to consumers.

Nickel is a secondary concern worth flagging. Certain reishi and lion’s mane samples have shown nickel concentrations in the 1.5–3.0 ppm range. The USP <232> PDE for nickel (oral) is 200 µg/day — more generous than cadmium — but at high serving sizes and for consumers with nickel sensitivity, it’s still a variable worth tracking in your incoming material data.

Four Things Midwest Brands Should Do Before Their Next Mushroom Shipment

Audit your supplier CoAs for element-level specificity. A compliant CoA should list cadmium, lead, arsenic, and mercury individually, with actual quantitative results — not ranges, not “ND” without a stated detection limit, and not combined totals. If your supplier can’t provide element-specific results with a validated method reference, that’s a procurement conversation to have before the next purchase order is signed.

Build internal release limits that reflect your specific serving size. USP <232> PDEs are daily dose limits. Your raw material specification needs to account for your finished product serving size and the real possibility that your consumers are taking multiple supplement products. If your daily mushroom dose is 2,000 mg, a conservative cadmium specification for incoming powder is approximately 1.5–2.0 µg/g — not the raw PDE-equivalent, because you want analytical margin.

Test every production lot, not just your supplier qualification batch. Cadmium content in mushroom powders varies lot to lot from the same growing region, because it tracks soil conditions, harvest timing, and seasonal environmental factors. A qualification study on a supplier’s reference sample doesn’t protect you against a contaminated production lot three months later. Incoming testing at receipt is the only reliable control point under 21 CFR Part 111 §111.70(b).

Run the full USP <233> panel, not only Class 1 elements. Cadmium is the primary concern in mushrooms, but nickel and arsenic can appear at elevated concentrations in certain species, particularly reishi and some Cordyceps products. Adding the complete elemental impurities panel adds minimal cost on an ICP-MS run and gives you a complete, documentable picture — which matters when an FDA investigator reviews your incoming component testing records.

The Regulatory Reality

FDA has issued warning letters and initiated import alerts related to heavy metal contamination in botanical and mushroom-based supplements, and enforcement attention in this category has grown alongside consumer demand. The functional mushroom market isn’t slowing down. That means more products, more raw material imports flowing through Chicago, Houston, and Los Angeles, and more opportunities for a contaminated lot to pass a CoA-only review.

The brands getting this right aren’t necessarily the ones with the largest internal QA departments. They’re the ones who’ve built third-party ICP-MS verification at an ISO 17025-accredited analytical testing laboratory into their supply chain as a standard incoming step — not a discretionary budget line item.

Know what’s actually in your mushroom powder before it goes into your product. A quantitative cadmium result from a validated ICP-MS method, reported against your serving-size-specific control threshold, is the only number that should drive your release decision — not a checkbox on a supplier form.

---

Written by Nour Abochama, VP Operations, Qalitex | Quality Consultant, Ayah Labs. Learn more about our team

Ship your sample to our Chicago facility — get a Qalitex CoA in 5–7 days. Contact us

Related from our network

• ICP-MS Testing for Dietary Supplements Under USP <232>/<233> — Qalitex Laboratories’ ISO 17025-accredited elemental impurities methods for botanical raw materials and finished supplements, including Class 1–3 element panels
• Supplement Raw Material CoA Verification: What a Third-Party Lab Checks — How analytical review of incoming material CoAs, paired with independent ICP-MS confirmation, protects supplement brands from supply chain adulteration and contamination